Betaxolol, a β1-adrenoceptor antagonist, reduces Na+ influx into cortical synaptosomes by direct interaction with Na+ channels: Comparison with other β-adrenoceptor antagonists

British Journal of Pharmacology

Volumn 130, Issue 4, 2000, Pages 759-766

  Chidlow, Glyn ^a   Melena, José ^a   Osborne, Neville N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Batrachotoxin; Beta adrenoceptor antagonist; Betaxolol; Glaucoma; Neuroprotection; Voltage sensitive sodium channel

Indexed keywords

ATENOLOL; BATRACHOTOXININ A 20ALPHA BENZOATE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CARTEOLOL; LEVOBUNOLOL; NEUROTOXIN; PROPRANOLOL; RADIOLIGAND; SODIUM CHANNEL; SODIUM CHANNEL STIMULATING AGENT; SODIUM ION; TIMOLOL;

ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; DISSOCIATION CONSTANT; DRUG BINDING; DRUG INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM TRANSPORT;

EID: 0034080373     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703369     Document Type: Article

References (40)

1. BUCKLEY, M.M., GOA, K.L. & CLISSOLD, S.P. (1990). Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension. Drugs. 40, 75-90.
2. CARTER, A.J. (1998). The importance of voltage-dependent sodium channels in cerebral ischaemia. Amino Acids, 14, 159-169.
3. CATTERALL, W.A. (1987). Common modes of drug action on Na(+) channels: Local anesthetics, antiarrhythmics and anticonvulsants. Trends. Pharmacol. Sci., 8, 57-65.
4. COLLIGNON BRACH, J. (1994). Longterm effect of topical beta-blockers on intraocular pressure and visual field sensitivity in ocular hypertension and chronic open-angle glaucoma. Surv. Ophthalmol., 38 (Suppl): S149-S155.
5. DRANCE, S.M. (1998). A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma. J. Glaucoma, 7, 247-252.
6. DUNKLEY, P.R., HEATH, J.W., HARRISON, S.M., JARVIE, P.E., GLENFIELD, P.J. & ROSTAS, J.A. (1988). A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res., 441, 59-71.
7. FJELL, J., DIB HAJJ, S., FRIED, K., BLACK, J.A. & WAXMAN, S.G. (1997). Differential expression of sodium channel genes in retinal ganglion cells. Brain Res. Mol. Brain Res., 50, 197-204.
8. FOZZARD, H.A. & HANCK, D.A. (1996). Structure and function of voltage-dependent sodium channels: comparison of brain II and cardiac isoforms. Physiol. Rev., 76, 887-926.
9. 2+ channels controlling presynaptic release of glutamate. Ann. N.Y. Acad. Sci., 765, 210-229.
10. GRIMA, M., FREYSS BEGUIN, M., MILLANVOYE VAN BRUSSEL, E., DECKER, N. & SCHWARTZ, J. (1987). Effects of various antianginal drugs on sodium influx in rat brain synaptosomes and in rat heart muscle cells in culture. Eur. J. Pharmacol., 138, 1-8.
11. 3H]nitrendipine and on guinea pig left atria contractions. Eur. J. Pharmacol., 147, 173-185.
12. GROSS, R.L., HENSLEY, S.H. & WU, S.M. (1999). Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of β-blockers. Surv. Ophthalmol., 43, S162-S170.
13. 3H]batrachotoxinin A 20-alpha-benzoate binding site on voltage-sensitive sodium channels in rat brain. Biochem. Pharmacol., 36, 4239-4244.
14. KAISER, H.J., FLAMMER, J., MESSMER, C., STUMPFIG, D. & HENDRICKSON, P. (1992). Thirty-month visual field follow-up of glaucoma patients treated with beta-blockers. J. Glaucoma, 1, 153-155.
15. KAISER, H.J., FLAMMER, J., STUMPFIG, D. & HENDRICKSON, P. (1994). Longterm visual field follow-up of glaucoma patients treated with beta-blockers. Surv. Ophthalmol., 38 (Suppl): S156-S159.
16. 2+ channel antagonists and neuroprotection from cerebral ischemia. Eur. J. Pharmacol., 363, 1-15.
17. 2+ channels. Eur. J. Pharmacol., 378, 317-322.
18. MESSMER, C., FLAMMER, J. & STUMPFIG, D. (1991). Influence of betaxolol and timolol on the visual fields of patients with glaucoma. Am. J. Ophthalmol., 112, 678-681.
19. NARAHASHI, T., HUANG, C.S., SONG, J.H. & YEH, J.Z. (1997). Ion channels as targets for neuroprotective agents. Ann. N.Y. Acad. Sci., 825, 380-388.
20. +-channel down-modulation versus presynaptic glutamate release inhibition. Rev. Neurosci., 9, 203-211.
21. OSBORNE, N.N., CAZEVIEILLE, C., CARVALHO, A.L., LARSEN, A.K. & DESANTIS, L. (1997). In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res., 751, 113-123.
22. OSBORNE, N.N., CHIDLOW, G., NASH, M.S. & WOOD, J.P.M. (1999a). The potential of neuroprotection in glaucoma treatment. Curr. Opin. Ophthalmol., 10, 82-92.
23. OSBORNE, N.N., DE SANTIS, L.M., BAE, J.H., UGARTE, M., WOOD, J.P.M., NASH, M.S. & CHIDLOW, G. (1999b). Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. Exp. Eye Res., 69, 331-342.
24. OSBORNE, N.N., UGARTE, M., CHAO, M., CHIDLOW, G., BAE, J.H., WOOD, J.P. & NASH, M.S. (1999c). Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol., 43 (Suppl 1): S102-S128.
25. 3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by local anesthetics. Mol. Pharmacol., 25, 219-227.
26. 3H]-batrachotoxinin-A 20-alpha-benzoate binding to voltage-dependent sodium channels in rat cortical synaptosomes. Br. J. Pharmacol., 119, 1498-1504.
27. SASAKI, H., IGARASHI, Y., NISHIDA, K. & NAKAMURA, J. (1994). Intestinal permeability of ophthalmic beta-blockers for predicting ocular permeability. J. Pharm. Sci., 83, 1335-1338.
28. SETOGUCHI, M., OHYA, Y., ABE, I. & FUJISHIMA, M. (1995). Inhibitory action of betaxolol, a beta 1-selective adrenoceptor antagonist, on voltage-dependent calcium channels in guinea-pig artery and vein. Br. J. Pharmacol., 115, 198-202.
29. SHIMIDZU, T., ITOH, Y., TATSUMI, S., HAYASHI, S., UKAI, Y., YOSHIKUNI, Y. & KIMURA, K. (1997). Blockade of voltage-sensitive sodium channels by NS-7, a novel neuroprotective compound, in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 355, 601-608.
30. SORENSEN, S.J. & ABEL, S.R. (1996). Comparison of the ocular beta-blockers. Ann. Pharmacother., 30, 43-54.
31. STYS, P.K., RANSOM, B.R. & WAXMAN, S.G. (1992a). Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J. Neurophysiol., 67, 236-240.
32. STYS, P.K., WAXMAN, S.G. & RANSOM, B.R. (1992b). Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J. Neurosci., 12,430-439.
33. TAMKUN, M.M. & CATTERALL, W.A. (1981). Ion flux studies of voltage-sensitive sodium channels in synaptic nerve-ending particles. Mol. Pharmacol., 19, 78-86.
34. +-channels. Amino Acids, 14, 151-158.
35. 3H-tetracaine. Naunyn-Schmiedeberg's Arch. Pharmacol., 335, 176-182.
36. VORWERK, C.K., GORLA, M.S.R. & DREYER, E.B. (1999). An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy. Surv. Ophthalmol., 43, S142-S150.
37. WANG, W., SASAKI, H., CHIEN, D.S. & LEE, V.H. (1991). Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. Curr. Eye Res., 10, 571-579.
38. WAXMAN, S.G., BLACK, J.A., RANSOM, B.R. & STYS, P.K. (1994). Anoxic injury of rat optic nerve: ultrastructural evidence for coupling between Na+ influx and Ca(2+)-mediated injury in myelinated CNS axons. Brain Res., 644, 197-204.
39. 2+ entry blockers. Surv. Ophthalmol., 43 (Suppl 1): S214-S222.
40. ZIMMERMAN, T.J. (1993). Topical ophthalmic beta blockers: a comparative review. J. Ocul. Pharmacol., 9, 373-384.